Get the Stockscreener App
9.04
4.64%
-0.44
After Hours:
9.21
0.17
+1.88%
Mind Medicine Inc stock is traded at $9.04, with a volume of 1.96M.
It is down -4.64% in the last 24 hours and down -3.73% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$9.48
Open:
$9.5
24h Volume:
1.96M
Relative Volume:
1.60
Market Cap:
$687.84M
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-3.6898
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
-4.24%
1M Performance:
-3.73%
6M Performance:
+34.93%
1Y Performance:
+43.26%
1-Day Range:
$9.00
$9.5899
1-Week Range:
$9.00
$10.04
52-Week Range:
$4.70
$11.02
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.04 | 721.31M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation in Adults with Generalized Anxiety Disorder - Investing News Network
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD) - Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Mind Medicine at TD Cowen Summit: Strategic Insights into MM120 - Investing.com
Chart overlay techniques for tracking Mind Medicine (MindMed) Inc.2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Mind Medicine (MNMD) Advances Psychedelic Treatments for Anxiety and Depression - GuruFocus
Is Mind Medicine (MindMed) Inc. forming a reversal patternQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Buy Signal: Is Mind Medicine MindMed Incs ROIC above industry averageQuarterly Portfolio Review & Smart Money Movement Alerts - khodrobank.com
Market Trends: Can United Homes Group Inc. Equity Warrant outperform in the next rallyQuarterly Profit Summary & Low Drawdown Momentum Ideas - خودرو بانک
Chart Watch: Will Mind Medicine (MindMed) Inc. benefit from rate cutsEarnings Growth Summary & Consistent Profit Alerts - خودرو بانک
Trading Recap: Will StepStone Group Inc. benefit from rate cutsWeekly Trade Recap & Community Driven Trade Alerts - خودرو بانک
Bull Run: Can Mind Medicine MindMed Inc stock outperform in a bear marketJuly 2025 Big Picture & Safe Capital Allocation Plans - خودرو بانک
Mind Medicine (MindMed) Inc. stock prediction for this weekJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Stock Price Down 2.2% – Time to Sell? - Defense World
Quarterly Risk: What are analysts price targets for Mind Medicine MindMed Inc - khodrobank.com
Aug Volume: Can Mind Medicine (MindMed) Inc. expand into new marketsJuly 2025 Reactions & Weekly High Conviction Trade Ideas - خودرو بانک
Big Picture: Will Mind Medicine MindMed Inc stock hit new highs in YEARDip Buying & High Accuracy Investment Signals - خودرو بانک
What earnings revisions data tells us about Mind Medicine (MindMed) Inc.July 2025 Closing Moves & Free Safe Entry Trade Signal Reports - newser.com
Performance Recap: Is Mind Medicine MindMed Inc forming a breakout patternVolume Spike & Real-Time Buy Signal Alerts - خودرو بانک
MindMed to Participate in September Investor Conferences - Investing News Network
Mind Medicine at H.C. Wainwright: Strategic Insights on MM120 Trials - Investing.com
MindMed’s MM120 Shows Promise in Treating Generalized Anxiety Disorder - TipRanks
Aug Chart Watch: Is Mind Medicine (MindMed) Inc. stock suitable for long term investingWeekly Stock Analysis & Weekly Breakout Stock Alerts - Lancaster City Council
MindMed announces inducement grants - Medical Buyer
Mind Medicine (MindMed) Inc. $MNMD Shares Sold by Corebridge Financial Inc. - Defense World
78,750 Stock Options: MindMed's Latest Employee Inducement Grants for Brain Health Innovation Team - Stock Titan
MindMed Announces New Employee Inducement Grants - FinancialContent
Published on: 2025-09-08 21:39:10 - beatles.ru
RSI + MACD Show Convergence for Mind Medicine (MindMed) Inc.Market Sentiment Report & Daily Oversold Stock Bounce Ideas - beatles.ru
Technical Bounce Expected in Mind Medicine (MindMed) Inc. Next Week - beatles.ru
Understanding Mind Medicine (MindMed) Inc.’s price movementTrade Exit Summary & Stepwise Trade Signal Implementation - Newser
Mind Medicine’s LSD Dose Cuts Anxiety for 12 Weeks in Trial - WebProNews
PEAK6 LLC Lowers Holdings in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Institutional Investors in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) See US$100m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Using Python tools to backtest Mind Medicine (MindMed) Inc. strategiesMarket Trend Summary & Reliable Volume Spike Trade Alerts - Newser
Key resistance and support levels for Mind Medicine (MindMed) Inc.Profit Target & Step-by-Step Trade Execution Guides - Newser
Can Mind Medicine (MindMed) Inc. hit a new high this monthMarket Activity Summary & Consistent Income Trade Recommendations - Newser
What is the earnings history of Mind Medicine (MindMed) Inc.2025 Key Highlights & Free Daily Entry Point Trade Alerts - خودرو بانک
What the charts say about Mind Medicine (MindMed) Inc. todayWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Wellington Management Group LLP Has $1.32 Million Stock Position in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
How sentiment analysis helps forecast Mind Medicine (MindMed) Inc.2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Can you recover from losses in Mind Medicine (MindMed) Inc.Inflation Watch & Weekly Stock Breakout Alerts - Newser
Mind Medicine (MindMed) Inc. stock outlook for YEAR2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
When is the best time to exit Mind Medicine (MindMed) Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - Newser
Intraday pattern recognizer results for Mind Medicine (MindMed) Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser
Mind Medicine’s Breakthrough in Anxiety Disorder Treatment - TipRanks
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD) | Fina - FinancialContent
Is Mind Medicine (MindMed) Inc. reversing from oversold territoryMarket Performance Summary & Advanced Technical Signal Analysis - Newser
Full technical analysis of Mind Medicine (MindMed) Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD) | Dail - FinancialContent
Highs Report: Is Mind Medicine (MindMed) Inc. stock undervalued right nowTake Profit & Free Daily Entry Point Trade Alerts - خودرو بانک
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mind Medicine Inc Stock (MNMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer |
Jun 25 '25 |
Sale |
6.80 |
7,848 |
53,366 |
438,329 |
| Barrow Robert | Chief Executive Officer |
Jun 25 '25 |
Sale |
6.80 |
26,491 |
180,139 |
830,065 |
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):